SAN DIEGO, March 27, 2018 /PRNewswire/ — Renova™ Therapeutics, a biotechnology company developing gene and peptide-based treatments for cardiovascular and metabolic diseases, announced today that the European Patent Office has issued Patent No. 2814513, “Systemic Delivery and Regulated Expression of Paracrine Genes for Cardiovascular Diseases and Other Conditions” to The Regents of the […]